Present and potential future use of gene therapy for the treatment of non-insulin dependent diabetes mellitus (Review). [electronic resource]
Producer: 20000110Description: 585-92 p. digitalISSN:- 1107-3756
- Adult
- Animals
- Antigens, Neoplasm
- Biomarkers, Tumor
- Blood Glucose -- analysis
- Cell Transplantation
- Diabetes Mellitus, Type 2 -- genetics
- Gene Expression Regulation
- Genes, Synthetic
- Genetic Therapy
- Genetic Vectors
- Glucagon -- genetics
- Glucagon-Like Peptide 1
- Glucokinase -- genetics
- Glucose Transporter Type 2
- Homeodomain Proteins
- Humans
- Hyperinsulinism -- etiology
- Hypoglycemic Agents -- pharmacology
- Insulin -- genetics
- Insulin Resistance
- Insulin Secretion
- Islets of Langerhans -- drug effects
- Islets of Langerhans Transplantation
- Lectins, C-Type
- Mice
- Middle Aged
- Monosaccharide Transport Proteins -- genetics
- Muscle Contraction
- Nitric Oxide -- physiology
- Nitric Oxide Synthase -- genetics
- Nitric Oxide Synthase Type I
- Pancreatitis-Associated Proteins
- Peptide Fragments -- genetics
- Promoter Regions, Genetic
- Protein Precursors -- genetics
- Proteins -- genetics
- Rats
- Trans-Activators -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.